WebThe USPTO has given the DEBIOJECT trademark a serial number of 79150397. The federal status of this trademark filing is NOT AVAILABLE as of Friday, August 6, 2024. This … WebJan 21, 2024 · For instance, Debiotech in collaboration with multiple vaccine companies has announced the use of its DebioJect Microneedle drug delivery system for covid-19 vaccines. Zosano Pharma has unveiled ...
Debiotech - Overview, News & Competitors ZoomInfo.com
WebSingle hollow silicon microneedles (DebioJectTM) of 80-lm bore size and lengths of 400, 500, 600 or 700 lm, with apertures 200 lm from the tip, were supplied by Debiotech SA, Switzerland to investigate the effect of needle length on the depth of cell delivery to the skin. Human skin tissue Freshly excised human breast skin was obtained from ... WebMar 1, 2024 · Europe PMC is an archive of life sciences journal literature. Search life-sciences literature (Over 39 million articles, preprints and more) haywood investments
Safety, tolerability and efficacy of intradermal rabies
WebCision - MediaStudio View Media - PR Newswire WebMedical Design Excellence Award 2014 recipient Debiotech‘s innovative DebioJect device was designed to overcome the challenges of classical intradermal delivery techniques, while improving accurate site and dose delivery. Research institutions are working on projects with polymers and iontophoresis to assist drug delivery. WebMar 1, 2024 · Results demonstrated that the DebioJect™ is a safe, reliable and efficient device. Significant decreases of pain at needle insertion and at vaccine injection were reported with IDJ compared to IDS and IM. All local reactogenicity symptoms (pain, redness and pruritus) after injection with either vaccine or saline solution, were similar for IDJ ... haywood intranet